Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleMetformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial.AuthorsNanni, O.; Amadori, D.; De Censi, A.; Rocca, A.; Freschi, A.; Bologna, A.; Gianni, L.; Rosetti, F.; Amaducci, L.; Cavanna, L.; Foca, F.; Sarti, S.; Serra, P.; Valmorri, L.; Bruzzi, P.; Corradengo, D.; Gennari, A.; MYME investigatorsPublicationBreast Cancer Research & Treatment, 2019, Vol 174, Issue 2, p433ISSN0167-6806Publication typeArticleDOI10.1007/s10549-018-05070-2